Logo 222 0.2 Pill - yellow round, 7mm
Generic Name: naldemedine
Pill with imprint Logo 222 0.2 is Yellow, Round and has been identified as Symproic 0.2 mg. It is supplied by Shionogi Inc.
Symproic is used in the treatment of Opioid-Induced Constipation and belongs to the drug class peripheral opioid receptor antagonists. Symproic 0.2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 222 0.2
Symproic
- Generic Name
- naldemedine
- Imprint
- Logo 222 0.2
- Strength
- 0.2 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Peripheral opioid receptor antagonists
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shionogi Inc.
- National Drug Code (NDC)
- 59630-0222 (Discontinued)
- Inactive Ingredients
-
mannitol,
croscarmellose sodium,
magnesium stearate,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
Movantik
Movantik reduces constipation caused by opioid pain medicine used to treat severe chronic pain. It ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Relistor
Relistor reduces constipation caused by narcotic medications used to treat pain in people with ...
Entereg
Entereg (alvimopan) is used to speed recovery of stomach and intestinal functions after a ...
Naloxegol
Naloxegol systemic is used for constipation, constipation, chronic, constipation, drug induced ...
Naldemedine
Naldemedine systemic is used for constipation, opioid-induced constipation
Methylnaltrexone
Methylnaltrexone systemic is used for constipation, constipation, chronic, constipation, drug ...
More about Symproic (naldemedine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: peripheral opioid receptor antagonists
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.